By using Health-Shared, you agree to our Privacy Policy, including cookie policy. We use cookies to improve the users journey, but we don’t store any sensitive data and don’t use it any other way.
Dr Sheharyar Quraishi, Consultant Endocrinologist and Diabetologist talks about which sorts of people would benefit from SGLT-2 inhibitors. He explains that SGLT-2 inhibitors have been shown to have benefit in people with Diabetes as well as Coronary Artery Disease or reduced Kidney Function.